Collegium Pharmaceutical Inc. to Report Fourth Quarter and Full-Year 2025 Financial Results
Collegium Pharmaceutical, Inc. COLL | 32.31 | -2.83% |
Collegium Pharmaceutical Inc. will report its fourth quarter and full-year 2025 financial results before the market opens on Thursday, February 26, 2026. Following the release, the company will host a live conference call and webcast at 8:00 a.m. ET. The audio webcast will be accessible from the Investors section of the Company's website: www.collegiumpharma.com.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Collegium Pharmaceutical Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9651211-en) on February 12, 2026, and is solely responsible for the information contained therein.
